SARS-CoV2 Patients and Surgery: Interpreting Data from GlobalSurg-CovidSurg

Dmitri Nepogodiev, MBChB, ( Twitter: @CovidSurg) co-chief investigator, GlobalSurg-CovidSurg Week, University of Birmingham, U.K., on the work of this international prospective multicenter cohort study that aims to determine the optimal timing of surgery following COVID-19 infection and to determine and assess key global surgical indicators. He discusses some important findings, including that COVID-19 patients who receive surgery less than seven weeks from diagnosis have increased postoperative mortality, among other critical data points.